{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T14:51:13Z","timestamp":1780671073545,"version":"3.54.1"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,6,20]],"date-time":"2018-06-20T00:00:00Z","timestamp":1529452800000},"content-version":"am","delay-in-days":323,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004359","name":"Swedish Research council","doi-asserted-by":"publisher","award":["9459"],"award-info":[{"award-number":["9459"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Uppsala Berzelii Technology Centre for Neurodiagnostics"},{"DOI":"10.13039\/501100006353","name":"Kjell and M\u00e4rta Beijer Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006353","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003792","name":"Swedish Brain Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003792","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Swiss National Science Foundation","doi-asserted-by":"publisher","award":["P2EZP3_148644"],"award-info":[{"award-number":["P2EZP3_148644"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Swiss National Science Foundation","doi-asserted-by":"publisher","award":["P300P3_154635"],"award-info":[{"award-number":["P300P3_154635"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.ejps.2017.06.004","type":"journal-article","created":{"date-parts":[[2017,6,3]],"date-time":"2017-06-03T19:32:04Z","timestamp":1496518324000},"page":"345-351","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Importance of N- and C-terminal residues of substance P 1\u20137 for alleviating allodynia in mice after peripheral administration"],"prefix":"10.1016","volume":"106","author":[{"given":"Anna","family":"Skogh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Lesniak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabienne Z.","family":"Gaugaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Svensson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunnar","family":"Lindeberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Fransson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fred","family":"Nyberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathias","family":"Hallberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5720-2904","authenticated-orcid":false,"given":"Anja","family":"Sandstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2017.06.004_bb0005","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/papr.12050","article-title":"The costs and consequences of adequately managed chronic non-cancer pain and chronic neuropathic pain","volume":"14","author":"Andrew","year":"2014","journal-title":"Pain Pract."},{"key":"10.1016\/j.ejps.2017.06.004_bb0010","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/1744-8069-6-74","article-title":"Peripheral nerve injury and TRPV1-expressing primary afferent C-fibers cause opening of the blood-brain barrier","volume":"6","author":"Beggs","year":"2010","journal-title":"Mol. Pain"},{"key":"10.1016\/j.ejps.2017.06.004_bb0015","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0006-291X(75)80073-8","article-title":"Enzymatic inactivation of substance p by a partially purified enzyme from rat brain","volume":"65","author":"Benuck","year":"1975","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejps.2017.06.004_bb0020","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jpain.2003.12.004","article-title":"Clinical characteristics and economic costs of patients with painful neuropathic disorders","volume":"5","author":"Berger","year":"2004","journal-title":"J. Pain"},{"key":"10.1016\/j.ejps.2017.06.004_bb0025","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.peptides.2005.08.009","article-title":"Endomorphin-1 and endomorphin-2 differentially interact with specific binding sites for substance P (SP) aminoterminal SP1-7 in the rat spinal cord","volume":"27","author":"Botros","year":"2006","journal-title":"Peptides"},{"key":"10.1016\/j.ejps.2017.06.004_bb0030","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1016\/j.peptides.2008.05.014","article-title":"Endomorphins interact with the substance P (SP) aminoterminal SP(1-7) binding in the ventral tegmental area of the rat brain","volume":"29","author":"Botros","year":"2008","journal-title":"Peptides"},{"key":"10.1016\/j.ejps.2017.06.004_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.pain.2005.10.036","article-title":"Assessment and analysis of mechanical allodynia-like behavior induced by spared nerve injury (SNI) in the mouse","volume":"122","author":"Bourquin","year":"2006","journal-title":"Pain"},{"key":"10.1016\/j.ejps.2017.06.004_bb0040","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.pneurobio.2008.12.002","article-title":"Delivery of peptide and protein drugs over the blood-brain barrier","volume":"87","author":"Brasnjevic","year":"2009","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.ejps.2017.06.004_bb0045","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.ejphar.2009.10.006","article-title":"Substance P1-7 induces antihyperalgesia in diabetic mice through a mechanism involving the naloxone-sensitive sigma receptors","volume":"626","author":"Carlsson","year":"2010","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejps.2017.06.004_bb0050","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.ejphar.2014.05.060","article-title":"N-terminal truncations of substance P 1\u20137 amide affect its action on spinal cord injury-induced mechanical allodynia in rats","volume":"738","author":"Carlsson-Jonsson","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejps.2017.06.004_bb0055","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/nrd2368","article-title":"Modelling of the blood-brain barrier in drug discovery and development","volume":"6","author":"Cecchelli","year":"2007","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejps.2017.06.004_bb0060","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0165-0270(94)90144-9","article-title":"Quantitative assessment of tactile allodynia in the rat paw","volume":"53","author":"Chaplan","year":"1994","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.ejps.2017.06.004_bb0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev.neuro.051508.135531","article-title":"Neuropathic pain: a maladaptive response of the nervous system to damage","volume":"32","author":"Costigan","year":"2009","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.ejps.2017.06.004_bb0070","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0014-2999(01)01460-1","article-title":"Opposite effects of substance P fragments C (anxiogenic) and N (anxiolytic) injected into dorsal periaqueductal gray","volume":"432","author":"De Ara\u00fajo","year":"2001","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejps.2017.06.004_bb0075","doi-asserted-by":"crossref","first-page":"8143","DOI":"10.1021\/acs.jafc.5b01824","article-title":"Transport of antihypertensive peptide RVPSL, ovotransferrin 328\u2013332, in human intestinal Caco-2 cell monolayers","volume":"63","author":"Ding","year":"2015","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.ejps.2017.06.004_bb0080","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1080\/01621459.1965.10480843","article-title":"The up-and-down method for small samples","volume":"60","author":"Dixon","year":"1965","journal-title":"J. Am. Stat. Assoc."},{"key":"10.1016\/j.ejps.2017.06.004_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.pain.2007.08.033","article-title":"Pharmacologic management of neuropathic pain: evidence-based recommendations","volume":"132","author":"Dworkin","year":"2007","journal-title":"Pain"},{"key":"10.1016\/j.ejps.2017.06.004_bb0090","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.npep.2007.11.002","article-title":"Small peptides mimicking substance P (1-7) and encompassing a C-terminal amide functionality","volume":"42","author":"Fransson","year":"2008","journal-title":"Neuropeptides"},{"key":"10.1016\/j.ejps.2017.06.004_bb0095","doi-asserted-by":"crossref","first-page":"4953","DOI":"10.1021\/jm400209h","article-title":"Constrained H-Phe-Phe-NH2 analogues with high affinity to the substance P 1\u20137 binding site and with improved metabolic stability and cell permeability","volume":"56","author":"Fransson","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejps.2017.06.004_bb0100","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1021\/ml5002954","article-title":"Exploration and pharmacokinetic profiling of phenylalanine based carbamates as novel substance P 1\u20137 analogues","volume":"5","author":"Fransson","year":"2014","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejps.2017.06.004_bb0105","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0196-9781(01)00592-7","article-title":"Investigation of substance P transport across the blood-brain barrier","volume":"23","author":"Freed","year":"2002","journal-title":"Peptides"},{"key":"10.1016\/j.ejps.2017.06.004_bb0110","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/0196-9781(83)90033-5","article-title":"Substance P and behavior: opposite effects of N-terminal and C-terminal fragments","volume":"4","author":"Hall","year":"1983","journal-title":"Peptides"},{"key":"10.1016\/j.ejps.2017.06.004_bb0115","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1002\/med.21323","article-title":"Neuropeptides: metabolism to bioactive fragments and the pharmacology of their receptors","volume":"35","author":"Hallberg","year":"2015","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ejps.2017.06.004_bb0120","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2174\/1389203033380313","article-title":"Neuropeptide conversion to bioactive fragments - an important pathway in neuromodulation","volume":"4","author":"Hallberg","year":"2003","journal-title":"Curr. Protein Pept. Sci."},{"key":"10.1016\/j.ejps.2017.06.004_bb0125","doi-asserted-by":"crossref","first-page":"3364","DOI":"10.1523\/JNEUROSCI.14-05-03364.1994","article-title":"The NH2-terminus of substance P modulates NMDA-induced activity in the mouse spinal cord","volume":"14","author":"Hornfeldt","year":"1994","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejps.2017.06.004_bb0130","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0014-2999(96)00199-9","article-title":"Evidence that the NH2-terminus of substance P modulates N-methyl-d-aspartate-induced activity by an action involving sigma receptors","volume":"306","author":"Hornfeldt","year":"1996","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejps.2017.06.004_bb0135","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1042\/bj2840595","article-title":"A survey of membrane peptidases in two human colonic cell lines, Caco-2 and HT-29","volume":"284","author":"Howell","year":"1992","journal-title":"Biochem. J."},{"key":"10.1016\/j.ejps.2017.06.004_bb0140","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1038\/nprot.2007.303","article-title":"Determination of drug permeability and prediction of drug absorption in Caco-2 monolayers","volume":"2","author":"Hubatsch","year":"2007","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ejps.2017.06.004_bb0145","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0166-4328(94)00132-Y","article-title":"The role of neuropeptides in learning: focus on the neurokinin substance P","volume":"66","author":"Huston","year":"1995","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ejps.2017.06.004_bb0150","doi-asserted-by":"crossref","first-page":"3653","DOI":"10.1523\/JNEUROSCI.10-11-03653.1990","article-title":"Specific binding of substance P aminoterminal heptapeptide [SP(1-7)] to mouse brain and spinal cord membranes","volume":"10","author":"Igwe","year":"1990","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejps.2017.06.004_bb0155","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1021\/cr800323s","article-title":"Amino acid-protecting groups","volume":"109","author":"Isidro-Llobet","year":"2009","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejps.2017.06.004_bb0160","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.neuroscience.2015.04.002","article-title":"Small constrained SP1-7 analogs bind to a unique site and promote anti-allodynic effects following systemic injection in mice","volume":"298","author":"Jonsson","year":"2015","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejps.2017.06.004_bb0165","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0014-2999(95)00342-I","article-title":"Substance P-(1-7) and substance P-(5-11) locally modulate dopamine release in rat striatum","volume":"282","author":"Khan","year":"1995","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejps.2017.06.004_bb0170","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/0306-4522(96)00119-4","article-title":"N- and C-terminal substance P fragments modulate striatal dopamine outflow through a cholinergic link mediated by muscarinic receptors","volume":"73","author":"Khan","year":"1996","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejps.2017.06.004_bb0175","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/S0022-3565(25)21174-0","article-title":"The substance P amino-terminal metabolite substance P(1-7), administered peripherally, prevents the development of acute morphine tolerance and attenuates the expression of withdrawal in mice","volume":"279","author":"Kreeger","year":"1996","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejps.2017.06.004_bb0180","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.neuroscience.2016.06.057","article-title":"Antidepressants and gabapentinoids in neuropathic pain: mechanistic insights","volume":"338","author":"Kremer","year":"2016","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejps.2017.06.004_bb0185","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/j.pain.2014.01.026","article-title":"Blood-nerve barrier dysfunction contributes to the generation of neuropathic pain and allows targeting of injured nerves for pain relief","volume":"155","author":"Lim","year":"2014","journal-title":"Pain"},{"key":"10.1016\/j.ejps.2017.06.004_bb0190","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1093\/bioinformatics\/btq054","article-title":"Skyline: an open source document editor for creating and analyzing targeted proteomics experiments","volume":"26","author":"MacLean","year":"2010","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ejps.2017.06.004_bb0195","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/0306-3623(94)00292-U","article-title":"The mammalian tachykinin receptors","volume":"26","author":"Maggi","year":"1995","journal-title":"Gen. Pharmacol."},{"key":"10.1016\/j.ejps.2017.06.004_bb0200","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/377532a0","article-title":"Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor","volume":"377","author":"Meunier","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.ejps.2017.06.004_bb0205","doi-asserted-by":"crossref","first-page":"147","DOI":"10.2174\/138945007779315597","article-title":"Peptide conversion--a potential pathway modulating G-protein signaling","volume":"8","author":"Nyberg","year":"2007","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.ejps.2017.06.004_bb0210","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S0006-291X(84)80360-5","article-title":"Characterization of substance P(1-7) and (1-8) generating enzyme in human cerebrospinal fluid","volume":"125","author":"Nyberg","year":"1984","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejps.2017.06.004_bb0215","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.peptides.2010.09.029","article-title":"The effect of substance P1-7 amide on nociceptive threshold in diabetic mice","volume":"32","author":"Ohsawa","year":"2011","journal-title":"Peptides"},{"key":"10.1016\/j.ejps.2017.06.004_bb0220","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1358\/mf.2004.26.3.809722","article-title":"Occurrence of substance P(1-7) in the metabolism of substance P and its antinociceptive activity at the mouse spinal cord level","volume":"26","author":"Sakurada","year":"2004","journal-title":"Methods Find. Exp. Clin. Pharmacol."},{"key":"10.1016\/j.ejps.2017.06.004_bb0225","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1749-6632.1977.tb41843.x","article-title":"ACTH: a short introductory review","volume":"297","author":"Schwyzer","year":"1977","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.ejps.2017.06.004_bb0230","doi-asserted-by":"crossref","first-page":"12251","DOI":"10.1021\/jo4020613","article-title":"Aminocarbonylation of 4-iodo-1H-imidazoles with an amino acid amide nucleophile: synthesis of constrained H-Phe-Phe-NH2 analogues","volume":"78","author":"Skogh","year":"2013","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.ejps.2017.06.004_bb0235","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/0196-9781(82)90027-4","article-title":"A fragment of substance P with specific central activity: SP(1-7)","volume":"3","author":"Stewart","year":"1982","journal-title":"Peptides"},{"key":"10.1016\/j.ejps.2017.06.004_bb0240","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1016\/j.peptides.2005.12.004","article-title":"Modulation of peripheral inflammation by the substance P N-terminal metabolite substance P1\u20137","volume":"27","author":"Wiktelius","year":"2006","journal-title":"Peptides"},{"key":"10.1016\/j.ejps.2017.06.004_bb0245","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0304-3940(01)02564-2","article-title":"Injection of substance P (SP) N-terminal fragment SP(1-7) into the ventral tegmental area modulates the levels of nucleus accumbens dopamine and dihydroxyphenylacetic acid in male rats during morphine withdrawal","volume":"320","author":"Zhou","year":"2002","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejps.2017.06.004_bb0250","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0196-9781(02)00287-5","article-title":"Substance P(1-7) affects the expression of dopamine D2 receptor mRNA in male rat brain during morphine withdrawal","volume":"24","author":"Zhou","year":"2003","journal-title":"Peptides"},{"key":"10.1016\/j.ejps.2017.06.004_bb0255","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1016\/j.peptides.2011.06.030","article-title":"Substance P N-terminal fragment SP(1-7) attenuates chronic morphine tolerance and affects dynorphin B and nociceptin in rats","volume":"32","author":"Zhou","year":"2011","journal-title":"Peptides"}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098717303366?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098717303366?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T11:45:43Z","timestamp":1760528743000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098717303366"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":51,"alternative-id":["S0928098717303366"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2017.06.004","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Importance of N- and C-terminal residues of substance P 1\u20137 for alleviating allodynia in mice after peripheral administration","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2017.06.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}